Madureira Amanda Rangel, Martins Vinicius Valois Pereira, Cardoso Janete Corrêa, Torezani-Sales Suellem, Miranda Kiany de Oliveira, Salgado Breno Souza, Monteiro Lidianne Narducci, Nogueira Breno Valentim, Leopoldo André Soares, Lima-Leopoldo Ana Paula
Postgraduate Program in Nutrition and Health, Health Sciences Center, Department of Integrated Health Education, Federal University of Espírito Santo, Vitória, (Espírito Santo), Brazil.
Postgraduate Program in Physiological Science, Health Sciences Center, Department of Physiological Sciences, Federal University of Espírito Santo, Vitória, (Espírito Santo), Brazil.
Cell Physiol Biochem. 2025 Jul 7;59(4):434-452. doi: 10.33594/000000791.
BACKGROUND/AIMS: Obesity Resistance (OR) is characterized by limited weight gain and reduced fat accumulation despite an obesogenic diet. However, the metabolic risk, particularly regarding Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), remains unclear. The current study aims to investigate the presence of MASLD, as well as metabolic parameters and morphological aspects of adipose tissues in obesity-resistant (OR) R rats fed a high-fat diet (HFD).
ale Wistar rats (n=71) were initially randomized into two groups: a) standard diet (SD, n=35) and b) high-fat diet (HFD, n=36). The protocol was performed for 14 weeks, including 4 weeks of induction and 10 weeks of exposure to obesity. Subsequently, after applying the tertile classification criterion, the animals were redistributed into three groups: a) control (C, n=12), fed a standard diet; b) obesity-prone (OP, n=12); and c) OR (n=12). Body weight evolution, adiposity, nutritional behavior, metabolic markers, and liver morphology were assessed, along with the staging of MASLD.
OR rats exhibited lower body weight, total fat pads, and leptin compared to OP but higher values than C. MASLD was observed in 50% of OR animals, while 37.5% progressed to metabolic dysfunction-associated steatohepatitis (MASH). OP rats had a higher incidence of MASH (87.5%).
Chronic HFD exposure in OR rats lead to metabolic changes and MASLD development, including MASH, demonstrating that OR does not protect against HFD-induced hepatic alterations.
背景/目的:抗肥胖(OR)的特征是尽管食用致肥胖饮食,但体重增加有限且脂肪堆积减少。然而,代谢风险,尤其是与代谢功能障碍相关的脂肪性肝病(MASLD),仍不清楚。本研究旨在调查高脂饮食(HFD)喂养的抗肥胖(OR)R大鼠中MASLD的存在情况,以及脂肪组织的代谢参数和形态学方面。
将71只雄性Wistar大鼠最初随机分为两组:a)标准饮食(SD,n = 35)和b)高脂饮食(HFD,n = 36)。实验方案进行14周,包括4周的诱导期和10周的肥胖暴露期。随后,应用三分位数分类标准后,将动物重新分为三组:a)对照组(C,n = 12),喂食标准饮食;b)易肥胖组(OP,n = 12);c)抗肥胖组(OR,n = 12)。评估体重变化、肥胖程度、营养行为、代谢指标和肝脏形态,以及MASLD的分期。
与OP组相比,OR组大鼠体重、总脂肪垫和瘦素水平较低,但高于C组。50%的OR组动物出现MASLD,其中37.5%进展为代谢功能障碍相关脂肪性肝炎(MASH)。OP组大鼠MASH的发生率更高(87.5%)。
OR大鼠长期暴露于HFD会导致代谢变化和MASLD的发展,包括MASH,表明OR不能预防HFD诱导的肝脏改变。